Our data suggests that with Omadas support, patients are able to persist on their medications to achieve meaningful weight loss, which improves outcomes and protects ROI
The effect of vitamin deficiency can range from night blindness, anemia to permanent neural disorders, depending on the particular deficient vitamin
The first DPP-4 inhibitor, sitagliptin, was approved by the FDA in 2006 and by the EMA in 2007
When combined with baseline metabolic biomarkers (fasting glucose, insulin, lipid profile, inflammatory markers), genetic insights from the Precision Peptide test can help your provider evaluate whether GLP-1 therapy aligns with your individual risk profile and comorbidity burden
Our providers will help determine which option best fits your goals, health history, and lifestyle
Protein also helps you feel more satisfied after eating, which could make it easier to stick to a calorie deficit